Compounds > carbostyril
Page last updated: 2024-08-17

carbostyril and AIDS Seroconversion

carbostyril has been researched along with AIDS Seroconversion in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chuang, YC; Hung, CC; Kuo, PH; Liu, WC; Sun, HY; Wu, PY1
Antinori, A; Castagna, A; Costantini, A; Cozzi-Lepri, A; d'Arminio Monforte, A; Di Biagio, A; Gianotti, N; Lo Caputo, S; Marchetti, G; Mazzarello, G; Mazzotta, V; Rusconi, S1
Chen, FE; Gu, SX; He, QQ; Liu, J; Wu, HQ; Yang, LM; Zhang, X; Zheng, YT1
Aghokeng, AF; Chaix, ML; Monleau, M; Nkano, BA; Peeters, M1
Bousquet, J; Demoly, P; Godard, P; Michel, FB1

Reviews

1 review(s) available for carbostyril and AIDS Seroconversion

ArticleYear
[Update on drug allergies induced by antibiotics and anti-retroviral agents].
    Bulletin de l'Academie nationale de medecine, 2000, Volume: 184, Issue:4

    Topics: Anti-Bacterial Agents; Anti-HIV Agents; Drug Hypersensitivity; HIV Seropositivity; Humans; Macrolides; Penicillins; Quinolones

2000

Other Studies

4 other study(ies) available for carbostyril and AIDS Seroconversion

ArticleYear
Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 92

    Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cobicistat; Dyslipidemias; Emtricitabine; Female; HIV Seropositivity; Humans; Lipids; Male; Middle Aged; Quinolones; Retrospective Studies; Tenofovir; Weight Gain

2020
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting.
    The Journal of antimicrobial chemotherapy, 2019, 05-01, Volume: 74, Issue:5

    Topics: Adult; CD4 Lymphocyte Count; Cobicistat; Cohort Studies; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; HIV Seropositivity; Humans; Italy; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Quinolones; Raltegravir Potassium; Regression Analysis; Survival Analysis; Treatment Failure

2019
Structural modifications of quinolone-3-carboxylic acids with anti-HIV activity.
    Bioorganic & medicinal chemistry, 2011, Aug-15, Volume: 19, Issue:16

    Topics: Anti-HIV Agents; Carboxylic Acids; Cell Line, Tumor; Cell Survival; HIV Infections; HIV Seropositivity; HIV-1; Humans; Models, Molecular; Quinolones; Structure-Activity Relationship

2011
Drug resistance mutations of HIV type 1 non-B viruses to integrase inhibitors in treatment-naive patients from sub-saharan countries and discordant interpretations.
    AIDS research and human retroviruses, 2012, Volume: 28, Issue:9

    Topics: Africa South of the Sahara; Algorithms; Amino Acid Sequence; DNA, Viral; Drug Resistance, Viral; Female; HIV Integrase; HIV Integrase Inhibitors; HIV Seropositivity; Humans; Male; Molecular Sequence Data; Mutation; Pyrrolidinones; Quinolones; Raltegravir Potassium

2012